Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INGENOL MEBUTATE Cause Application site infection? 22 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Application site infection have been filed in association with INGENOL MEBUTATE. This represents 0.7% of all adverse event reports for INGENOL MEBUTATE.

22
Reports of Application site infection with INGENOL MEBUTATE
0.7%
of all INGENOL MEBUTATE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Application site infection From INGENOL MEBUTATE?

Of the 22 reports, 1 (4.5%) required hospitalization.

Is Application site infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INGENOL MEBUTATE. However, 22 reports have been filed with the FAERS database.

What Other Side Effects Does INGENOL MEBUTATE Cause?

Application site erythema (1,373) Application site pain (1,012) Application site vesicles (843) Application site exfoliation (586) Drug administered at inappropriate site (500) Application site swelling (489) Application site scab (451) Application site dryness (365) Incorrect drug administration duration (339) Application site pruritus (291)

What Other Drugs Cause Application site infection?

BECAPLERMIN (96) MINOXIDIL (24) BUPRENORPHINE (22) FENTANYL (17) MECHLORETHAMINE (13) DOCOSANOL (12) EPOPROSTENOL (6) ESTRADIOL (6) NICOTINE (5) TREPROSTINIL (5)

Which INGENOL MEBUTATE Alternatives Have Lower Application site infection Risk?

INGENOL MEBUTATE vs INLYTA INGENOL MEBUTATE vs INOTERSEN INGENOL MEBUTATE vs INOTUZUMAB OZOGAMICIN INGENOL MEBUTATE vs INSULIN INGENOL MEBUTATE vs INSULIN ASPART

Related Pages

INGENOL MEBUTATE Full Profile All Application site infection Reports All Drugs Causing Application site infection INGENOL MEBUTATE Demographics